Article
Overexpression of PLCG2 and TMEM38A inhibit tumor progression in clear cell renal cell carcinoma
25 Jan 2025
Abstract excerpt
Clear cell renal cell carcinoma is a prevalent urological malignancy, imposing substantial burdens on both patients and society. In our study, we used bioinformatics methods to select four putative target genes associated with EMT and prognosis and developed a nomogram model which could accurately predicting 5-year patient survival rates. We further analyzed proteome and single-cell data and selected PLCG2 and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
